Management changes at Molecular Insight
This article was originally published in Scrip
Executive Summary
Molecular Insight Pharmaceuticals (US) has appointed Daniel Peters president and chief executive officer; he has also been elected to the company's board of directors. Mr Peters assumes the positions that had been held by Dr John Babich, a company founder, who will now serve as executive vice-president, chief scientific officer and president of R&D, alongside continuing as a member of the board of directors. Mr Peters was most recently president and CEO of the medical diagnostics business at GE Healthcare.